Effect of Radical Surgery for Advanced Adenocarcinoma of Esophagogastric Junction on Perioperative Cellular Cell Immunity

References

• Rubinkiewicz M, Migaczewski M, Hankus J, et al. The number of regulatory Foxp3+ T-cells in different stages of malignant transformation of large intestinal polyps. Adv Med Sci. 2016;61(2):306–310. doi: 10.1016/j.advms.2016.03.008.
   PubMed Web of Science ®Google Scholar
• Kim R. Effects of surgery and anesthetic choice on immunosuppression and cancer recurrence. J Transl Med. 2018;16:8.
   PubMed Web of Science ®Google Scholar
• Fernandez E, Cacheux W, Frossard JL, et al. Exclusive neoadjuvant chemotherapy in locally advanced resectable gastric and gastro-esophageal junction adenocarcinoma. Dig Liver Dis. 2017;49(5):552–556. doi: 10.1016/j.dld.2016.12.025.
   PubMedGoogle Scholar
• Takaya S, Saito H, Ikeguchi M. Upregulation of immune checkpoint molecules, PD 1 and LAG 3, on CD4 and CD8 T cells after gastric cancer surgery. Yonago Acta Med. 2015;58:39–44.
   PubMed Web of Science ®Google Scholar
• Ng CS, Lee TW, Wan S, et al. Thoracotomy is associated with significantly more profound suppression in lymphocytes and natural killer cells than video-assisted thoracic surgery following major lung resections for cancer. J Invest Surg. 2005;18(2):81–88. doi: 10.1080/08941930590926320.
   PubMed Web of Science ®Google Scholar
• Ananth AA, Tai LH, Lansdell C, et al. Surgical stress abrogates pre-existing protective T cell mediated anti-tumor immunity leading to postoperative cancer recurrence. PLoS ONE. 2016;11(5):e0155947. doi: 10.1371/journal.pone.0155947.
   PubMed Web of Science ®Google Scholar
• Własiuk P, Putowski M, Giannopoulos K. PD1/PD1L pathway, HLA-G and T regulatory cells as new markers of immunosuppression in cancers. Postepy Hig Med Dosw (Online). 2016;70(0):1044–1058.
   PubMedGoogle Scholar
• Chen L, Sun L, Lang Y, et al. Fast-track surgery improves postoperative clinical recovery and cellular and humoral immunity after esophagectomy for esophageal cancer. BMC Cancer 2016;16:449.
   PubMed Web of Science ®Google Scholar
• Xu D, Li J, Song Y, et al. Laparoscopic surgery contributes more to nutritional and immunologic recovery than fast-track care in colorectal cancer. World J Surg Onc. 2015;13(1):18. doi: 10.1186/s12957-015-0445-5.
   PubMedGoogle Scholar
• Shoumiao LI, Zhizhong Z, Wei Z, et al. Influence of hyperthermic intraperitoneal perfusion chemotherapy on cellular immune function in adenocarcinoma of esophagogastric junction after radical operation. Chin J Gen Surg. 2017;32:1047–1049. 李守淼,张志忠,张伟,等.食管胃交界部腺癌术后腹腔热灌注化疗对细胞免疫的影响. 中华普通外科杂志. 2017;32:1047–1049.
   Google Scholar
• Schmidt A, Eriksson M, Shang MM, et al. Comparative analysis of protocols to induce human CD4+Foxp3+ regulatory T cells by combinations of IL-2, TGF-beta, retinoic acid, rapamycin and butyrate. PLoS ONE. 2016;11(2):e0148474 doi: 10.1371/journal.pone.0148474.
   PubMed Web of Science ®Google Scholar
• deLeeuw RJ, Kroeger DR, Kost SE, et al. CD25 identifies a subset of CD4 + FoxP3 TIL that are exhausted yet prognostically favorable in human ovarian cancer. Cancer Immunol Res. 2015;3(3):245–253. doi: 10.1158/2326-6066.CIR-14-0146.
   PubMed Web of Science ®Google Scholar
• Wu M, Chen X, Lou J, et al. Changes in regulatory T cells in patients with ovarian cancer undergoing surgery: Preliminary results. Int Immunopharmacol. 2017;47:244–250. doi: 10.1016/j.intimp.2017.04.004.
   PubMed Web of Science ®Google Scholar
• Zhang CH, Huang Y. Effect of peripheral blood CD4 + CD25 + regulatory T cell on postoperative immunotherapy for patients with renal carcinoma. Asian Pac J Cancer Prev. 2016;17(4):2027–2030. doi: 10.7314/APJCP.2016.17.4.2027.
   PubMedGoogle Scholar
• Song QK, Ren J, Zhou XN, et al. The prognostic value of peripheral CD4+CD25+ T lymphocytes among early stage and triple negative breast cancer patients receiving dendritic cells-cytokine induced killer cells infusion. Oncotarget. 2015;6:41350–41359.
   PubMedGoogle Scholar
• Zhang S, Pan SB, Lyu QH, et al. Postoperative regulatory T-cells and natural killer cells in stage I nonsmall cell lung cancer underwent video-assisted thoracoscopic lobectomy or thoracotomy. Chin Med J (Engl). 2015;128(11):1502–1509. doi: 10.4103/0366-6999.157672.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Wang B, Wu J, et al. Association of preoperative EpCAM circulating tumor cells and peripheral Treg cell levels with early recurrence of hepatocellular carcinoma following radical hepatic resection. BMC Cancer 2016;16:506.
   PubMed Web of Science ®Google Scholar
• Si TG, Wang JP, Guo Z. Analysis of circulating regulatory T cells (CD4+CD25+Foxp3+CD127–) after cryosurgery in prostate cancer. Asian J Androl. 2013;15(4):461–465. doi: 10.1038/aja.2013.22.
   PubMed Web of Science ®Google Scholar
• Pakkala S, Owonikoko TK. Immune checkpoint inhibitors in small cell lung cancer. J Thorac Dis. 2018;10(Suppl 3):S460–S467. doi: 10.21037/jtd.2017.12.51.
   PubMed Web of Science ®Google Scholar
• Deng WW, Mao L, Yu GT, et al. LAG 3 confers poor prognosis and its blockade reshapes antitumor response in head and neck squamous cell carcinoma. Oncoimmunology 2016;5(11):e1239005. doi: 10.1080/2162402X.2016.1239005.
   PubMed Web of Science ®Google Scholar
• Liu C, Lu J, Tian H, et al. Increased expression of PD-L1 by the human papillomavirus 16 E7 oncoprotein inhibits anticancer immunity. Mol Med Rep. 2017;15(3):1063–1070. doi: 10.3892/mmr.2017.6102.
   PubMed Web of Science ®Google Scholar
• Xu P, Zhang P, Sun Z, et al. Surgical trauma induces postoperative T-cell dysfunction in lung cancer patients through the programmed death-1 pathway. Cancer Immunol Immunother. 2015;64(11):1383–1392. doi: 10.1007/s00262-015-1740-2.
   PubMed Web of Science ®Google Scholar
• Saito H, Kuroda H, Matsunaga T, et al. Increased PD-1 expression on CD4+ and CD8+ T cells is involved in immune evasion in gastric cancer. J Surg Oncol. 2013;107(5):517–522. doi: 10.1002/jso.23281.
   PubMed Web of Science ®Google Scholar
• Liang LIU, Li-Xin Y, Chao-Jing LU, et al. Survival analysis the impact of the number of negative lymph nodes negative lymph node in Siewert II adenocarcinoma of the esophagogastrci junction without lymphatic metastasis. J Prac Med. 2016;32:3878–3881. 徐志云,刘良,杨立信,等. 淋巴结清扫数目对淋巴结转移阴性SiewertII型食管胃交界部癌的影响. 实用医学杂志. 2016;32:3878–3881 (Chinese).
   Google Scholar
• Rice TW, Patil DT, Blackstone EH. 8th edition AJCC/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice. Ann Cardiothorac Surg. 2017;6(2):119–130. doi: 10.21037/acs.2017.03.14.
   PubMed Web of Science ®Google Scholar
• Yoon H, Kim N. Diagnosis and management of high risk group for gastric cancer. Gut Liver. 2015;9(1):5–17. doi: 10.5009/gnl14118.
   PubMed Web of Science ®Google Scholar
• Zhang NN, Chen JN, Xiao L, et al. Accumulation Mechanisms of CD4(+)CD25(+)FOXP3(+) regulatory T cells in EBV-associated gastric carcinoma. Sci Rep. 2015;5:18057.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Du W, Chen Z, et al. Upregulation of PD-L1 by SPP1 mediates macrophage polarization and facilitates immune escape in lung adenocarcinoma. Exp Cell Res. 2017;359(2):449–457. doi: 10.1016/j.yexcr.2017.08.028.
   PubMed Web of Science ®Google Scholar
• Sellitto A, Galizia G, De Fanis U, et al. Behavior of circulating CD4+CD25+Foxp3+ regulatory T cells in colon cancer patients undergoing surgery. J Clin Immunol. 2011;31(6):1095–1104. doi: 10.1007/s10875-011-9585-8.
   PubMed Web of Science ®Google Scholar
• Cui M, Gong C, Jiang B, et al. Evaluation of immune responses of gastric cancer patients treated by laparoscopic and open gastrectomy. Med Oncol. 2015;32:253.
   PubMed Web of Science ®Google Scholar
• Dong Y, Sun Q, Zhang X. PD-1 and its ligands are important immune checkpoints in cancer. Oncotarget. 2017;8(2):2171–2186. doi: 10.18632/oncotarget.13895.
   PubMed Web of Science ®Google Scholar
• Fear VS, Poh WP, Valvis S, et al. Timing of excision after a non-severe burn has a significant impact on the subsequent immune response in a murine model. Burns. 2016;42(4):815–824. doi: 10.1016/j.burns.2016.01.013.
   PubMed Web of Science ®Google Scholar
• Kouo T, Huang L, Pucsek AB, et al. Galectin-3 shapes antitumor immune responses by suppressing CD8+ T cells via LAG-3 and inhibiting expansion of plasmacytoid dendritic cells. Cancer Immunol Res. 2015;3(4):412–423. doi: 10.1158/2326-6066.CIR-14-0150.
   PubMed Web of Science ®Google Scholar
• Kano Y, Iguchi T, Matsui H, et al. Combined adjuvants of poly(I:C) plus LAG-3-Ig improve antitumor effects of tumor-specific T cells, preventing their exhaustion. Cancer Sci. 2016;107(4):398–406. doi: 10.1111/cas.12861.
   PubMed Web of Science ®Google Scholar
• Woo SR, Turnis ME, Goldberg MV, et al. Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape. Cancer Res. 2012;72(4):917–927. doi: 10.1158/0008-5472.CAN-11-1620.
   PubMed Web of Science ®Google Scholar